Laurion Capital Management »

Lexeo Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4M 255k 13.42

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A Call Option (META)
Apple (AAPL)
Tesla Motors Call Option (TSLA)
Kenvue (KVUE)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Adobe Systems Incorporated Call Option (ADBE)
Alphabet Cap Stk Cl C Call Option (GOOG)
Bridgebio Pharma (BBIO)
NVIDIA Corporation Call Option (NVDA)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Intel Corporation Call Option (INTC)

View all positions for Laurion Capital Management

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Omega Fund Management
Citadel Advisors
Blackstone Group
Artal Group
Vanguard Group
Laurion Capital Management
Cornell University
Citigroup
Millennium Management
Jane Street
Point72 Middle East FZE
Bank of New York Mellon
Cubist Systematic Strategies

View all funds holding Lexeo Therapeutics